Rchr
J-GLOBAL ID：201801019554043047
Update date: Dec. 20, 2024
Mori Seiichi
Mori Seiichi
Affiliation and department：
Research field (1)：
Tumor diagnostics and therapeutics
Papers (96)：
-
Yuri Sakimoto, Kohei Kumegawa, Shimpei Matsui, Tomohiro Yamaguchi, Toshiki Mukai, Koji Okabayashi, Seiichi Mori, Yuko Kitagawa, Takashi Akiyoshi, Reo Maruyama. Single-cell RNA-seq analysis of cancer-endothelial cell interactions in primary tumor and peritoneal metastasis from a single patient with colorectal cancer. BJC reports. 2024. 2. 1. 88-88
-
Osamu Gotoh, Yuko Sugiyama, Akiko Tonooka, Mayuko Kosugi, Sunao Kitaura, Ryu Minegishi, Masatoshi Sano, Sayuri Amino, Rie Furuya, Norio Tanaka, et al. Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma. The Journal of pathology. 2024
-
Hiroaki Hiramatsu, Rui Yokomori, Liu Shengyi, Norio Tanaka, Seiichi Mori, Kazuma Kiyotani, Osamu Gotoh, Shigeru Kusumoto, Nobuaki Nakano, Youko Suehiro, et al. Clinical landscape of TP73 structural variants in ATL patients. Leukemia. 2023. 37. 12. 2502-2506
-
Ippei Fukada, Seiichi Mori, Naomi Hayashi, Mari Hosonaga, Wang Xiaofei, Masumi Yamazaki, Arisa Ueki, Kazuma Kiyotani, Akiko Tonooka, Kengo Takeuchi, et al. Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice. Cancer Science. 2023. 114. 12. 4632-4642
-
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, et al. Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer. 2023
ｍore...
MISC (16)：
-
Osamu Gotoh, Kazuma Kiyotani, Yuko Sugiyama, Yutaka Takazawa, Kazuyoshi Kato, Norio Tanaka, Hidetaka Nomura, Kosei Hasegawa, Keiichi Fujiwara, Shiro Takamatsu, et al. Immunogenomic Landscape of Gynecologic Carcinosarcoma. CANCER SCIENCE. 2021. 112. 827-827
-
小倉 淳司, 秋吉 高志, 山本 智理子, 河内 洋, 石川 雄一, 森 誠一, 大庭 幸治, 梛野 正人, 福長 洋介, 上野 雅資. 直腸癌における術前化学放射線療法とPD-L1の発現及びCD8陽性T細胞の関係性について. 日本消化器外科学会総会. 2019. 74回. P134-5
-
小倉 淳司, 秋吉 高志, 山本 智理子, 河内 洋, 石川 雄一, 森 誠一, 大庭 幸治, 梛野 正人, 福長 洋介, 上野 雅資. 直腸癌における術前化学放射線療法とPD-L1の発現及びCD8陽性T細胞の関係性について. 日本消化器外科学会総会. 2019. 74回. P134-5
-
横溝 智雅, 森 誠一, 黒川 峰夫, 大里 元美, 小松 則夫. Hlfの発現は造血幹細胞の発生経路特異的に観察される(Hlf expression marks the developmental pathway for hematopoietic stem cells but not for erythroid-myeloid progenitors). 日本癌学会総会記事. 2018. 77回. 1849-1849
-
Mohammad Asad, Wong Meng Kang, Tan Tuan Zea, Mahesh Choolani, Jeffery Low, Seiichi Mori, Jean Paul Thiery, Ruby Yun-Ju Huang. FZD7 drives aggressiveness in stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway. CLINICAL CANCER RESEARCH. 2015. 21
ｍore...
Return to Previous Page
